Nevro, Boston Sci Settle Spine-Stim Patent Dispute
Executive Summary
Nevro and Boston Scientific have resolved a patent dispute involving spinal cord stimulation technologies.
You may also be interested in...
Nevro Files Patent Suit Against Stimwave
Chronic pain treatment company Nevro has filed suit against rival Stimwave Tech alleging patent infringement.
Mixed Final Ruling In Nevro, Boston Sci Patent Spat
A California federal judge delivered a mixed verdict in a patent dispute between Nevro Corp. and Boston Scientific. The court said that some of Nevro's claims were patent-eligible, but further ruled that Boston Scientific had not infringed those patents.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.